title: Role of systems pharmacology in understanding drug adverse events.
abstract: Systems pharmacology involves the application of systems biology approaches, combining large-scale experimental studies with computational analyses, to the study of drugs, drug targets, and drug effects. Many of these initial studies have focused on identifying new drug targets, new uses of known drugs, and systems-level properties of existing drugs. This review focuses on systems pharmacology studies that aim to better understand drug side effects and adverse events. By studying the drugs in the context of cellular networks, these studies provide insights into adverse events caused by off-targets of drugs as well as adverse events-mediated complex network responses. This allows rapid identification of biomarkers for side effect susceptibility. In this way, systems pharmacology will lead to not only newer and more effective therapies, but safer medications with fewer side effects.
authors.affiliation: Department of Pharmacology and Systems Biology Center New York, Mount Sinai School of Medicine, New York, NY, USA.
authors.forename: Seth I
authors.initials: SI
authors.lastname: Berger
authors.forename: Ravi
authors.initials: R
authors.lastname: Iyengar
mesh_terms: D016503:Drug Delivery Systems; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D010600:Pharmacology; D049490:Systems Biology
references.citation: J Electrocardiol. 2004;37 Suppl:7-14
references.pmid: 15534787
references.citation: Nature. 2009 Nov 12;462(7270):175-81
references.pmid: 19881490
references.citation: Genome Med. 2009 Jan 22;1(1):11
references.pmid: 19348698
references.citation: Bioinformatics. 2009 Oct 1;25(19):2466-72
references.pmid: 19648136
references.citation: Mt Sinai J Med. 2010 Jul-Aug;77(4):333-44
references.pmid: 20687178
references.citation: Curr Opin Hematol. 2006 Sep;13(5):357-61
references.pmid: 16888441
references.citation: J Investig Dermatol Symp Proc. 2003 Jun;8(1):72-5
references.pmid: 12894998
references.citation: Nucleic Acids Res. 2008 Jan;36(Database issue):D919-22
references.pmid: 17942422
references.citation: Am J Hematol. 2009 Jul;84(7):428-34
references.pmid: 19459150
references.citation: J Pharmacol Toxicol Methods. 2006 Mar-Apr;53(2):87-105
references.pmid: 16289936
references.citation: Nucleic Acids Res. 2009 Jul;37(Web Server issue):W406-12
references.pmid: 19417066
references.citation: Med Hypotheses. 2009 Nov;73(5):770-80
references.pmid: 19501473
references.citation: Annu Int Conf IEEE Eng Med Biol Soc. 2009;2009:5452-5
references.pmid: 19964679
references.citation: Drug Saf. 2009;32(2):111-8
references.pmid: 19236118
references.citation: Toxicol Appl Pharmacol. 2009 Jun 15;237(3):317-30
references.pmid: 19362101
references.citation: J Biotechnol. 2009 Nov;144(3):224-33
references.pmid: 19616593
references.citation: Pharmacogenomics. 2009 Jun;10(6):961-9
references.pmid: 19530963
references.citation: PLoS Comput Biol. 2009 May;5(5):e1000387
references.pmid: 19436720
references.citation: Science. 2008 Jul 11;321(5886):263-6
references.pmid: 18621671
references.citation: J Med Chem. 2009 May 14;52(9):3103-7
references.pmid: 19378990
references.citation: Congest Heart Fail. 2006 Jul-Aug;12(4):223-6
references.pmid: 16894282
references.citation: Bioinformatics. 2009 Sep 1;25(17):2244-50
references.pmid: 19528085
references.citation: Nat Biotechnol. 2008 Mar;26(3):343-51
references.pmid: 18297058
references.citation: Mt Sinai J Med. 2007 Apr;74(1):27-32
references.pmid: 17516560
references.citation: Regul Pept. 2009 Jun 5;155(1-3):11-7
references.pmid: 19345246
references.citation: Sci Signal. 2010 Apr 20;3(118):ra30
references.pmid: 20407125
references.citation: FEBS Lett. 2008 Apr 9;582(8):1283-90
references.pmid: 18291108
references.citation: Ann Intern Med. 1992 Aug 1;117(3):234-42
references.pmid: 1616218
references.citation: Curr Opin Drug Discov Devel. 2010 May;13(3):297-309
references.pmid: 20443163
references.citation: PLoS Comput Biol. 2009 Jul;5(7):e1000441
references.pmid: 19629158
references.citation: Expert Opin Investig Drugs. 2006 Jun;15(6):625-35
references.pmid: 16732715